USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | - | - | $-0.00 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | - | - | $9.06M |
Cumberland Pharmaceuticals's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 0 | $0.00 | $0.00 | $0.00 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 1 / 0 | $0.14 | $0.14 | $0.14 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 1 | $44.85M | $44.85M | $44.85M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | - | $-0.26 | - |
| Nov 9, 2021 | Sep 2021 | $-0.04 | $-0.07 | -77.25% |
| Aug 10, 2021 | Jun 2021 | $-0.07 | $-0.00 | 98.43% |
| May 11, 2021 | Mar 2021 | $-0.07 | $0.07 | 200.00% |
| Mar 9, 2021 | Dec 2020 | $-0.01 | $0.01 | 200.00% |
| Nov 10, 2020 | Sep 2020 | $-0.07 | $0.02 | 128.57% |
| Aug 11, 2020 | Jun 2020 | $0.03 | $0.08 | 166.67% |
| May 20, 2020 | Mar 2020 | $0.02 | $0.01 | -50.00% |
| Mar 18, 2020 | Dec 2019 | $0.01 | $0.09 | 800.00% |
| Nov 12, 2019 | Sep 2019 | $0.11 | $0.01 | -90.91% |
| Aug 14, 2019 | Jun 2019 | $0.07 | $0.10 | 42.86% |
| May 14, 2019 | Mar 2019 | $-0.11 | $0.11 | 200.00% |
| Feb 26, 2019 | Dec 2018 | $-0.16 | $0.10 | 162.50% |
| Nov 13, 2018 | Sep 2018 | $-0.19 | $-0.05 | 73.68% |
| Aug 14, 2018 | Jun 2018 | $-0.08 | $0.01 | 112.50% |
| May 8, 2018 | Mar 2018 | $-0.02 | $-0.09 | -350.00% |
| Mar 9, 2018 | Dec 2017 | $-0.02 | $-0.05 | -154.50% |
| Nov 7, 2017 | Sep 2017 | - | $-0.05 | - |
| Aug 8, 2017 | Jun 2017 | - | $-0.32 | - |
| May 15, 2017 | Mar 2017 | - | $-0.08 | - |
| Mar 7, 2017 | Dec 2016 | - | $-0.05 | - |
| Oct 25, 2016 | Sep 2016 | - | $0.01 | - |
| Aug 2, 2016 | Jun 2016 | - | $-0.00 | - |
| May 3, 2016 | Mar 2016 | - | $-0.02 | - |
| Mar 4, 2016 | Dec 2015 | - | $0.01 | - |
| Nov 4, 2015 | Sep 2015 | - | $0.01 | - |
| Aug 5, 2015 | Jun 2015 | - | $0.02 | - |
| May 8, 2015 | Mar 2015 | - | $0.00 | - |
| Mar 4, 2015 | Dec 2014 | - | $0.04 | - |
| Nov 5, 2014 | Sep 2014 | - | $0.04 | - |
| Aug 6, 2014 | Jun 2014 | - | $0.04 | - |
| May 14, 2014 | Mar 2014 | - | $0.02 | - |
| Mar 4, 2014 | Dec 2013 | $0.05 | $-0.08 | -260.00% |
| Nov 5, 2013 | Sep 2013 | - | $-0.04 | - |
| Aug 6, 2013 | Jun 2013 | $0.02 | $-0.03 | -250.00% |
| May 2, 2013 | Mar 2013 | $0.05 | $0.05 | - |
| Feb 28, 2013 | Dec 2012 | $0.14 | $0.12 | -14.29% |
| Nov 1, 2012 | Sep 2012 | $0.09 | $0.10 | 11.11% |
| Aug 2, 2012 | Jun 2012 | $0.07 | $0.09 | 28.57% |
| May 3, 2012 | Mar 2012 | $0.05 | $0.02 | -60.00% |
| Feb 29, 2012 | Dec 2011 | $0.05 | $0.04 | -20.00% |
| Nov 3, 2011 | Sep 2011 | $0.06 | $0.09 | 50.00% |
| Aug 4, 2011 | Jun 2011 | $0.04 | $0.11 | 175.00% |
| May 4, 2011 | Mar 2011 | $0.03 | $0.03 | - |
| Mar 8, 2011 | Dec 2010 | $0.03 | $0.04 | 33.33% |
| Nov 11, 2010 | Sep 2010 | $0.01 | $0.05 | 400.00% |
| Aug 16, 2010 | Jun 2010 | $0.03 | $0.01 | -66.67% |
| May 13, 2010 | Mar 2010 | $0.02 | $0.02 | - |
| Mar 10, 2010 | Dec 2009 | $0.01 | $0.01 | - |
| Nov 10, 2009 | Sep 2009 | $0.01 | $0.10 | 900.00% |
| Aug 27, 2009 | Jun 2009 | - | $0.02 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | $0.00 | $-0.26 | - |
| Mar 9, 2021 | Dec 2020 | $-0.03 | $0.12 | - |
| Mar 18, 2020 | Dec 2019 | $0.24 | $0.31 | 29.17% |
| Feb 26, 2019 | Dec 2018 | $-0.29 | $-0.03 | - |
| Mar 9, 2018 | Dec 2017 | - | $-0.50 | - |
| Mar 7, 2017 | Dec 2016 | - | $-0.06 | - |
| Mar 4, 2016 | Dec 2015 | - | $0.04 | - |
| Mar 4, 2015 | Dec 2014 | - | $0.14 | - |
| Mar 4, 2014 | Dec 2013 | - | $-0.10 | - |
| Feb 28, 2013 | Dec 2012 | - | $0.33 | - |
| Feb 29, 2012 | Dec 2011 | - | $0.27 | - |
| Mar 8, 2011 | Dec 2010 | - | $0.12 | - |
| Mar 10, 2010 | Dec 2009 | - | $0.13 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | $8.32M | $8.32M | 1.00% |
| Nov 9, 2021 | Sep 2021 | $9.19M | $8.07M | 0.88% |
| Aug 10, 2021 | Jun 2021 | $9.05M | $9.06M | 1.00% |
| May 11, 2021 | Mar 2021 | $8.50M | $10.54M | 1.24% |
| Mar 9, 2021 | Dec 2020 | $9.78M | $10.26M | 1.05% |
| Nov 10, 2020 | Sep 2020 | $8.61M | $9.25M | 1.07% |
| Aug 11, 2020 | Jun 2020 | $9.27M | $9.60M | 1.04% |
| May 20, 2020 | Mar 2020 | $9.46M | $8.33M | 0.88% |
| Mar 18, 2020 | Dec 2019 | $11.34M | $13.68M | 1.21% |
| Nov 12, 2019 | Sep 2019 | $12.65M | $10.37M | 0.82% |
| Aug 14, 2019 | Jun 2019 | $12.59M | $11.58M | 0.92% |
| May 14, 2019 | Mar 2019 | $10.70M | $11.90M | 1.11% |
| Feb 26, 2019 | Dec 2018 | $10.98M | $13.50M | 1.23% |
| Nov 13, 2018 | Sep 2018 | $9.16M | $8.49M | 0.93% |
| Aug 14, 2018 | Jun 2018 | $9.94M | $10.16M | 1.02% |
| May 8, 2018 | Mar 2018 | $9.71M | $8.59M | 0.88% |
| Mar 9, 2018 | Dec 2017 | - | $11.65M | - |
| Nov 7, 2017 | Sep 2017 | - | $11.20M | - |
| Aug 8, 2017 | Jun 2017 | - | $8.67M | - |
| May 15, 2017 | Mar 2017 | - | $9.64M | - |
| Mar 7, 2017 | Dec 2016 | - | $9.08M | - |
| Oct 25, 2016 | Sep 2016 | - | $8.79M | - |
| Aug 2, 2016 | Jun 2016 | - | $7.41M | - |
| May 3, 2016 | Mar 2016 | - | $7.74M | - |
| Mar 4, 2016 | Dec 2015 | - | $8.04M | - |
| Nov 4, 2015 | Sep 2015 | - | $7.89M | - |
| Aug 5, 2015 | Jun 2015 | - | $8.91M | - |
| May 8, 2015 | Mar 2015 | - | $8.69M | - |
| Mar 4, 2015 | Dec 2014 | - | $9.33M | - |
| Nov 5, 2014 | Sep 2014 | - | $9.73M | - |
| Aug 6, 2014 | Jun 2014 | - | $9.75M | - |
| May 14, 2014 | Mar 2014 | - | $8.09M | - |
| Mar 4, 2014 | Dec 2013 | - | $8.16M | - |
| Nov 5, 2013 | Sep 2013 | - | $6.53M | - |
| Aug 6, 2013 | Jun 2013 | - | $7.08M | - |
| May 2, 2013 | Mar 2013 | - | $10.26M | - |
| Feb 28, 2013 | Dec 2012 | - | $13.70M | - |
| Nov 1, 2012 | Sep 2012 | - | $12.53M | - |
| Aug 2, 2012 | Jun 2012 | - | $12.37M | - |
| May 3, 2012 | Mar 2012 | - | $10.26M | - |
| Feb 29, 2012 | Dec 2011 | - | $13.03M | - |
| Nov 3, 2011 | Sep 2011 | - | $13.05M | - |
| Aug 4, 2011 | Jun 2011 | - | $14.39M | - |
| May 4, 2011 | Mar 2011 | - | $10.67M | - |
| Mar 8, 2011 | Dec 2010 | - | $12.81M | - |
| Nov 11, 2010 | Sep 2010 | - | $12.19M | - |
| Aug 16, 2010 | Jun 2010 | - | $10.74M | - |
| May 13, 2010 | Mar 2010 | - | $10.13M | - |
| Mar 10, 2010 | Dec 2009 | - | $10.71M | - |
| Nov 10, 2009 | Sep 2009 | - | $13.60M | - |
| Aug 27, 2009 | Jun 2009 | - | $9.82M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | $35.98M | $35.99M | 0.00% |
| Mar 9, 2021 | Dec 2020 | $36.96M | $37.44M | 1.30% |
| Mar 18, 2020 | Dec 2019 | $45.20M | $47.53M | 5.16% |
| Feb 26, 2019 | Dec 2018 | $38.23M | $40.74M | 6.57% |
| Mar 9, 2018 | Dec 2017 | - | $41.15M | - |
| Mar 7, 2017 | Dec 2016 | - | $33.03M | - |
| Mar 4, 2016 | Dec 2015 | - | $33.52M | - |
| Mar 4, 2015 | Dec 2014 | - | $36.90M | - |
| Mar 4, 2014 | Dec 2013 | - | $32.03M | - |
| Feb 28, 2013 | Dec 2012 | - | $48.85M | - |
| Feb 29, 2012 | Dec 2011 | - | $51.14M | - |
| Mar 8, 2011 | Dec 2010 | - | $45.88M | - |
| Mar 10, 2010 | Dec 2009 | - | $43.54M | - |
CPIX's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.
Cumberland Pharmaceuticals's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.
Cumberland Pharmaceuticals's previous annual earnings date was Mar 8, 2022 for its fiscal year ended Dec 31, 2021.
CPIX's earnings per share (EPS) was $-0.26, missing the consensus analysts forecast of $0.00 by % , and lower than the previous year's EPS (Dec 2020) by -318.33%.
Revenues were $35.99M, better than the forecast of $35.98M by 0.00%, and down by -3.89% from previous year's revenue.
The company reported a net income of $-3.60M.
Cumberland Pharmaceuticals reported a free cash flow of $4.24M for its fiscal year, compared to $3.30M a year ago.
The company ended the fiscal year with $17.03M in total debt, a decrease of -6.45% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
